Targeting HER2-positive breast cancer: advances and future directions
Sandra M. SwainDepartment of Medicine, Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Washington, DC, USA. [email protected]Mythili ShastrySarah Cannon Research Institute, Nashville, TN, USAErika HamiltonSarah Cannon Research Institute, Nashville, TN, USA
2022en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 30 references